Indiana Tech Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Tech Watch.

Press releases published on October 9, 2026

28 minutes ago

TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq

Indeterminate GlobeNewswire

31 minutes ago

NETCLASS TECHNOLOGY INC Expands Business Horizons with Strategic Entry into AI Companion Smart Hardware

Indeterminate GlobeNewswire

31 minutes ago

Cloudastructure to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

Indeterminate GlobeNewswire

31 minutes ago

AZIO AI Signs First Hosting Agreement at Atlas One with Power Champion; 10 MW Contracted, with Expansion Rights to 50 MW Representing Up to Approximately $450 Million in Capacity Reservation Charges

Indeterminate GlobeNewswire

31 minutes ago

Braiin Ltd. to Participate in AI Panel at 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

31 minutes ago

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

Indeterminate GlobeNewswire

an hour ago

Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical

Indeterminate GlobeNewswire

an hour ago

Nuvectis Pharma to Participate in the Maxim Growth Summit 2026

Indeterminate GlobeNewswire

an hour ago

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Indeterminate GlobeNewswire

an hour ago

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

an hour ago

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

Indeterminate GlobeNewswire

an hour ago

Rezolve Ai Opens Retail to Any AI Shopping Agent with RezolvePay, Targeting a Multi-Trillion-Dollar Commerce Opportunity

Indeterminate GlobeNewswire

an hour ago

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Indeterminate GlobeNewswire

an hour ago

CENTEL Announces Masternode Participation Model and Blockchain Development Roadmap

Indeterminate GlobeNewswire

an hour ago

Stride to Appoint Steven Guttentag and Dylan Haggart to Board of Directors and Form Capital Allocation Committee

Indeterminate GlobeNewswire

2 hours ago

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference 

Indeterminate GlobeNewswire

2 hours ago

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

Indeterminate GlobeNewswire

2 hours ago

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference

Indeterminate GlobeNewswire

2 hours ago

Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions

Indeterminate GlobeNewswire